Nutramedic &Cosmetics Observational data impact of Luzixine™ consumption on health status of malnourished population FIGURE 5
Pomalive
®
Promising results in fight against dyslipidemia Oral supplement containing Hydroxytyrosol and Punicalagin could help improve Dyslipidemia in an adult population without co-adjuvant treatment
A
Example of applications LRD offers ideas for innovative nutraceutical concepts based on Luzixine™, for major market targets. In each of the applications, Luzixine™ is associated with a complementary micronutrient for optimized formulas. LUZIXINE™ CYCLE+ A programme dedicated to women during menstruation. A 5 g stick format rich in iron, combined with magnesium and vitamin B6 to helo reduce fatique. LUZIXINE™ HEALTHY AGING A healthy dose of essential nutrients to preserve health capital. A formula enriched with zinc, in the form of 1 g tablets to be taken twice daily – two in the morning and two in the evening – to reach in the recommending daily dose of 4 g. LUZIXINE™ ENDURANCE To naturally optimise the training and recovery of athletes. A 10 g formula enriched with vitamin C, in the form of capsules, powder sticks or stand-up pouches to sprinkle on food or to add to shakes and snacks.
ccording to recently published data from a randomised, double-blind, placebo-controlled stu dy , supplementation with Euromed’s ingredient Pomalive®, a precise combination of standardized olive and pomegranate fruits extracts, could help to improve dyslipidemia, a condition resulting from an unbalanced distribution of different lipids (triglyce rides, total cholesterol, HDL cholesterol and LDL cholesterol). Researchers from the Nutrition Department, University Hospital La Paz (Madrid, Spain) found that oral intake of patent pending combined olives and pomegranate extracts (Pomalive®) for 8 weeks (n = 84) significantly reduced plasma triglycerides (p < 0.05), decreased LDL-C (p < 0.01) and increased HDL-C (p < 0.05) in middle-aged participants with dyslipidemia, without co-adjuvant treatment, and no adverse effects were observed. Currently, statins are the most effective class of drugs for improving lipid profiles but up to 10% of patients experience side-effects that reduce compliance, thus limiting the risk reduction potential. Therefore, safe and effective alternatives are of great clinical interest. According to the researchers, the described improvements in the plasma lipid profiles of dyslipidemic subjects could contribute significantly to the improvement in endothelial dysfunction, arterial prehypertension and hypertension, as well as circulating plasma levels of oxLDL, as reported in 2019 . Pomalive® is a patent pending precise combination of standardized polyphenols obtained from po megranate and olive fruits. Processed with an eco- friendly, water-only technology Pure-Hydro Pro cess®, it is free from contaminants, organic solvent residuals and toxins. The raw material of the selected fruits is grown locally in the Mediterranean region - close to the manufacturing plant - according to strict and transparent quality control protocols.
References:
Luzerne – Recherche et Développement (L.R.D.) Complexe Agricole du Mont Bernard – BP 149 51008 Châlons en Champagne Contact : Tel : +33 3 254 22 62 e-mail: lrd@luzerne-rd.fr www.luzixine.fr
1
Quirós-Fernández R et al. Nutrients. 2022 Apr 29;14(9):1879
2
Nutrients 2019, 11(3), 640; https://doi.org/10.3390/nu11030640
EUROMED S.A. is a leading producer of standardised botanical extracts and natural active substances for the pharmaceutical, nutraceutical, food and cosmetic industries. All extracts comply with worldwide GMP norms, international pharmacopoeias and regulations. www.euromedgroup.com
9
